image
RedHill Biopharma Ltd. RDHL
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - IL
Watchlist
$ 1.93
-7.88 %
$ 8.53 K
Market Cap
-0.01
P/E
BALANCE SHEET
18 M ASSETS
-21.71%
Growth Rates
1Year -21.71%
3Years -53.65%
5Years -24.61%
7Years -15.23%
10Years -4.59%
22.7 M LIABILITIES
8.33%
Growth Rates
1Year 8.33%
3Years -49.10%
5Years 10.02%
7Years 9.19%
10Years 19.44%
-4.68 M EQUITY
-226.34%
Growth Rates
1Year -226.34%
3Years -15.17%
5Years -1.51%
7Years -1.42%
10Years -1.73%
BALANCE SHEET DECOMPOSITION
Balance Sheet RedHill Biopharma Ltd.
image
Current Assets 11.9 M
Cash & Short-Term Investments 4.62 M
Receivables 3.57 M
Other Current Assets 3.73 M
Non-Current Assets 6.13 M
Long-Term Investments 0
PP&E 437 K
Other Non-Current Assets 5.7 M
25.59 %19.76 %20.66 %31.56 %Total Assets$18.0m
Current Liabilities 22.2 M
Accounts Payable 7.86 M
Short-Term Debt 353 K
Other Current Liabilities 14 M
Non-Current Liabilities 503 K
Long-Term Debt 3 K
Other Non-Current Liabilities 500 K
34.59 %61.64 %Total Liabilities$22.7m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
ASSETS
Cash & Cash Equivalents 4.6 5.6 20.0 29.5 29.3 29.0 29.0 16.5 53.8 21.5 5.9 11.9 16.8 14.1
Short Term Investments 0 0.8 15 K 8.5 0.5 18.8 24.2 29.8 12.4 36.6 17.1 0.3 1.6 4.6
Receivables 3.6 3.3 37.9 32.5 29.3 1.6 1.4 2.3 0.5 0.2 1.1 0 84 K 19 K
Inventory 3.7 4.4 11.0 14.8 6.5 1.9 0.8 0.7 1.1 (34.5) (15.0) (0.4) (1.0) (1.5)
Other Current Assets 77 K 2.1 17.0 3.8 4.9 1.8 1.4 2.6 1.2 2.2 2.0 61 K 0.1 70 K
Total Current Assets 11.9 16.1 85.9 89.2 70.5 53.2 56.8 51.7 67.8 60.5 26.0 12.6 18.6 18.7
PP&E 0.4 1.2 7.2 4.2 5.7 3.8 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1
Intangible Assets 5.5 5.6 65.6 71.6 87.9 16.9 5.3 5.3 6.1 6.1 2.6 1.6 1.3 1.2
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0.1 0.2 16.2 16.2 0.2 0.1 0.2 0.1 0.1 76 K 81 K 0 0
Other Long Term Assets 0.1 34 0.1 16.2 16.2 (20.7) (5.6) 0.2 0.1 0.1 76 K 81 K 75 K 73 K
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 18.0 23.0 158.9 181.2 180.2 74.1 62.4 57.3 74.2 66.8 28.9 14.3 20.1 20.2
LIABILITIES
Accounts Payable 7.9 3.3 4.2 11.7 11.6 4.2 3.3 4.8 60 K 0.1 66 K 0.9 0.3 0.3
Short Term Debt 0.4 0.7 116.2 1.6 1.7 0.8 0 0 0 0 0 0 0 0
Other Current Liabilities 14.0 16.0 77.0 68.2 60.0 5.6 7.1 7.0 5.3 5.4 1.7 1.5 0.8 0.2
Total Current Liabilities 22.2 20.0 197.5 81.5 73.2 10.6 10.4 11.8 5.4 5.5 1.7 2.4 1.1 0.5
Long Term Debt 3 K 0.5 6.4 86.2 85.2 3.0 0 0 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0.5 1.3 3.4 4.6 7.9 0.5 0.8 0.4 6.2 1.2 2.1 0 0 0.9
Total Liabilities 22.7 21.0 207.3 172.3 166.4 14.1 11.2 12.3 11.5 6.8 3.8 2.4 1.1 1.4
EQUITY
Common Stock 35.0 21.4 2.8 1.5 1.1 1.0 0.8 0.6 0.4 0.3 0.2 0.2 0.1 0.1
Retained Earnings (414.8) (407.7) (433.9) (367.9) (280.3) (208.4) (169.1) (132.9) (89.6) (61.9) (42.2) (33.3) (23.9) (15.2)
Other Accumulative Comprehensive Income/Loss 0 0 0 0 0 0 (0.3) (0.3) (0.2) (0.1) 90 K 63 K 39 K 15 K
Total Equity (4.7) 2.1 (48.4) 8.9 13.9 60.0 51.2 45.1 62.7 60.1 25.0 11.9 19.0 18.8
Total Liabilities and Equity 18.0 23.0 158.9 181.2 180.2 74.1 62.4 57.3 74.2 66.8 28.9 14.3 20.1 20.2
SHARES OUTSTANDING
Common Shares Outstanding 16.2 K 16.2 K 3.87 K 2.91 K 2.28 K 1.86 K 1.43 K 1.09 K 773 692 541 389 322 300 328